A Chinese version of the chemotherapy-induced alopecia distress scale based on reliability and validity assessment in breast cancer patients
Purpose Chemotherapy-induced alopecia is a common and emotionally traumatic side effect on breast cancer patients. In order to make up for the deficiency of measuring tools in China, our study aims at translating the chemotherapy-induced alopecia distress scale (CADS) into Chinese and evaluating the...
Gespeichert in:
Veröffentlicht in: | Supportive care in cancer 2020-09, Vol.28 (9), p.4327-4336 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 4336 |
---|---|
container_issue | 9 |
container_start_page | 4327 |
container_title | Supportive care in cancer |
container_volume | 28 |
creator | Cong, WeiLian Wu, YanNi Liu, LiPing Hu, MingYu Zhou, ChunLan |
description | Purpose
Chemotherapy-induced alopecia is a common and emotionally traumatic side effect on breast cancer patients. In order to make up for the deficiency of measuring tools in China, our study aims at translating the chemotherapy-induced alopecia distress scale (CADS) into Chinese and evaluating the psychometric properties of the Chinese version of CADS (CADS-C) in breast cancer patients.
Methods
The validity and reliability of CADS-C were measured by a questionnaire survey among 301 breast cancer patients from Chinese mainland. Construct validity was assessed through factor analysis and contrasted group comparisons. The validity of the content was examined by an experts group. The internal consistency and test–retest reliability were evaluated by calculating Cronbach’s alpha and the intraclass correlation coefficient.
Results
The content validity index was 0.94; a structure with three factors was revealed by exploratory factor analysis which explained 65.40% of the variance and proved by confirmatory factor analysis. The contrasted group comparisons showed significant differences among different degrees of alopecia. The average variance extracted and composite reliability and correlations between CADS and body image, quality of life and self-esteem proved the convergent validity. The Cronbach’s alpha and the intraclass correlation coefficient of the total scale were 0.90 and 0.89 respectively, indicating satisfactory internal consistency and time stability.
Conclusion
The scale appears to be a reliable and valid tool to measure chemotherapy-induced alopecia distress among breast cancer patients in China. |
doi_str_mv | 10.1007/s00520-019-05284-0 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2334700317</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A630447340</galeid><sourcerecordid>A630447340</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-aebeed568a2b6c3fcb459e20d06e9392717aca546409cd235654ef41f2c6721e3</originalsourceid><addsrcrecordid>eNp9kk1v1DAQhi0EokvhD3BAlrhwSfFX7Oa4WvElVeICZ8uxJ11XiR08SaX9D_xovN1CBUKVDx57nndmbL2EvObsgjNm3iNjrWAN411Tg0vVsCdkw5WUjZGye0o2rFO8UbJtz8gLxBvGuDGteE7OJO-4kFptyM8t3e1jAgR6CwVjTjQPdNkD9XuYcg2Kmw9NTGH1EKgb8ww-OhoiLgUQKXo3Au0d1mwVFxij6-MYlwN1KdBbN8Zwd0Cs-ARpoTHRvoDDhXqXPBQ6uyXWBL4kzwY3Iry638_J948fvu0-N1dfP33Zba8arwxbGgc9QGj1pRO99nLwvWo7ECwwDZ3shOHGedcqrVjng5CtbhUMig_CayM4yHPy7lR3LvnHCrjYKaKHcXQJ8opWSFkbMclNRd_-g97ktaQ6nRXKSMGMlvJxSmhpuBbdA3Vdv8zGNOSlOH9sbbdaMlXrKVapi_9QdQWYos8Jhljv_xKIk8CXjFhgsHOJkysHy5k9GsWejGKrUeydUexR9OZ-4rWfIPyR_HZGBeQJwJpK11AenvRI2V-Mwsfo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2426371629</pqid></control><display><type>article</type><title>A Chinese version of the chemotherapy-induced alopecia distress scale based on reliability and validity assessment in breast cancer patients</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Cong, WeiLian ; Wu, YanNi ; Liu, LiPing ; Hu, MingYu ; Zhou, ChunLan</creator><creatorcontrib>Cong, WeiLian ; Wu, YanNi ; Liu, LiPing ; Hu, MingYu ; Zhou, ChunLan</creatorcontrib><description>Purpose
Chemotherapy-induced alopecia is a common and emotionally traumatic side effect on breast cancer patients. In order to make up for the deficiency of measuring tools in China, our study aims at translating the chemotherapy-induced alopecia distress scale (CADS) into Chinese and evaluating the psychometric properties of the Chinese version of CADS (CADS-C) in breast cancer patients.
Methods
The validity and reliability of CADS-C were measured by a questionnaire survey among 301 breast cancer patients from Chinese mainland. Construct validity was assessed through factor analysis and contrasted group comparisons. The validity of the content was examined by an experts group. The internal consistency and test–retest reliability were evaluated by calculating Cronbach’s alpha and the intraclass correlation coefficient.
Results
The content validity index was 0.94; a structure with three factors was revealed by exploratory factor analysis which explained 65.40% of the variance and proved by confirmatory factor analysis. The contrasted group comparisons showed significant differences among different degrees of alopecia. The average variance extracted and composite reliability and correlations between CADS and body image, quality of life and self-esteem proved the convergent validity. The Cronbach’s alpha and the intraclass correlation coefficient of the total scale were 0.90 and 0.89 respectively, indicating satisfactory internal consistency and time stability.
Conclusion
The scale appears to be a reliable and valid tool to measure chemotherapy-induced alopecia distress among breast cancer patients in China.</description><identifier>ISSN: 0941-4355</identifier><identifier>ISSN: 1433-7339</identifier><identifier>EISSN: 1433-7339</identifier><identifier>DOI: 10.1007/s00520-019-05284-0</identifier><identifier>PMID: 31912364</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adult ; Aged ; Alopecia ; Alopecia - chemically induced ; Alopecia - psychology ; Analysis ; Antineoplastic Agents - administration & dosage ; Antineoplastic Agents - adverse effects ; Asian People ; Baldness ; Body Image ; Breast cancer ; Breast Neoplasms - drug therapy ; Cancer ; Cancer patients ; Care and treatment ; Chemotherapy ; Cross-Sectional Studies ; Factor Analysis, Statistical ; Female ; Humans ; Language ; Medicine ; Medicine & Public Health ; Middle Aged ; Nursing ; Nursing Research ; Oncology ; Original Article ; Pain Medicine ; Palliative care ; Psychometrics - methods ; Quality of Life ; Rehabilitation Medicine ; Reproducibility of Results ; Surveys ; Translating ; Validity</subject><ispartof>Supportive care in cancer, 2020-09, Vol.28 (9), p.4327-4336</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2020</rights><rights>COPYRIGHT 2020 Springer</rights><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-aebeed568a2b6c3fcb459e20d06e9392717aca546409cd235654ef41f2c6721e3</citedby><cites>FETCH-LOGICAL-c470t-aebeed568a2b6c3fcb459e20d06e9392717aca546409cd235654ef41f2c6721e3</cites><orcidid>0000-0002-2108-5627</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00520-019-05284-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00520-019-05284-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31912364$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cong, WeiLian</creatorcontrib><creatorcontrib>Wu, YanNi</creatorcontrib><creatorcontrib>Liu, LiPing</creatorcontrib><creatorcontrib>Hu, MingYu</creatorcontrib><creatorcontrib>Zhou, ChunLan</creatorcontrib><title>A Chinese version of the chemotherapy-induced alopecia distress scale based on reliability and validity assessment in breast cancer patients</title><title>Supportive care in cancer</title><addtitle>Support Care Cancer</addtitle><addtitle>Support Care Cancer</addtitle><description>Purpose
Chemotherapy-induced alopecia is a common and emotionally traumatic side effect on breast cancer patients. In order to make up for the deficiency of measuring tools in China, our study aims at translating the chemotherapy-induced alopecia distress scale (CADS) into Chinese and evaluating the psychometric properties of the Chinese version of CADS (CADS-C) in breast cancer patients.
Methods
The validity and reliability of CADS-C were measured by a questionnaire survey among 301 breast cancer patients from Chinese mainland. Construct validity was assessed through factor analysis and contrasted group comparisons. The validity of the content was examined by an experts group. The internal consistency and test–retest reliability were evaluated by calculating Cronbach’s alpha and the intraclass correlation coefficient.
Results
The content validity index was 0.94; a structure with three factors was revealed by exploratory factor analysis which explained 65.40% of the variance and proved by confirmatory factor analysis. The contrasted group comparisons showed significant differences among different degrees of alopecia. The average variance extracted and composite reliability and correlations between CADS and body image, quality of life and self-esteem proved the convergent validity. The Cronbach’s alpha and the intraclass correlation coefficient of the total scale were 0.90 and 0.89 respectively, indicating satisfactory internal consistency and time stability.
Conclusion
The scale appears to be a reliable and valid tool to measure chemotherapy-induced alopecia distress among breast cancer patients in China.</description><subject>Adult</subject><subject>Aged</subject><subject>Alopecia</subject><subject>Alopecia - chemically induced</subject><subject>Alopecia - psychology</subject><subject>Analysis</subject><subject>Antineoplastic Agents - administration & dosage</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Asian People</subject><subject>Baldness</subject><subject>Body Image</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - drug therapy</subject><subject>Cancer</subject><subject>Cancer patients</subject><subject>Care and treatment</subject><subject>Chemotherapy</subject><subject>Cross-Sectional Studies</subject><subject>Factor Analysis, Statistical</subject><subject>Female</subject><subject>Humans</subject><subject>Language</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Nursing</subject><subject>Nursing Research</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Pain Medicine</subject><subject>Palliative care</subject><subject>Psychometrics - methods</subject><subject>Quality of Life</subject><subject>Rehabilitation Medicine</subject><subject>Reproducibility of Results</subject><subject>Surveys</subject><subject>Translating</subject><subject>Validity</subject><issn>0941-4355</issn><issn>1433-7339</issn><issn>1433-7339</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kk1v1DAQhi0EokvhD3BAlrhwSfFX7Oa4WvElVeICZ8uxJ11XiR08SaX9D_xovN1CBUKVDx57nndmbL2EvObsgjNm3iNjrWAN411Tg0vVsCdkw5WUjZGye0o2rFO8UbJtz8gLxBvGuDGteE7OJO-4kFptyM8t3e1jAgR6CwVjTjQPdNkD9XuYcg2Kmw9NTGH1EKgb8ww-OhoiLgUQKXo3Au0d1mwVFxij6-MYlwN1KdBbN8Zwd0Cs-ARpoTHRvoDDhXqXPBQ6uyXWBL4kzwY3Iry638_J948fvu0-N1dfP33Zba8arwxbGgc9QGj1pRO99nLwvWo7ECwwDZ3shOHGedcqrVjng5CtbhUMig_CayM4yHPy7lR3LvnHCrjYKaKHcXQJ8opWSFkbMclNRd_-g97ktaQ6nRXKSMGMlvJxSmhpuBbdA3Vdv8zGNOSlOH9sbbdaMlXrKVapi_9QdQWYos8Jhljv_xKIk8CXjFhgsHOJkysHy5k9GsWejGKrUeydUexR9OZ-4rWfIPyR_HZGBeQJwJpK11AenvRI2V-Mwsfo</recordid><startdate>20200901</startdate><enddate>20200901</enddate><creator>Cong, WeiLian</creator><creator>Wu, YanNi</creator><creator>Liu, LiPing</creator><creator>Hu, MingYu</creator><creator>Zhou, ChunLan</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88J</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HEHIP</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2R</scope><scope>M2S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2108-5627</orcidid></search><sort><creationdate>20200901</creationdate><title>A Chinese version of the chemotherapy-induced alopecia distress scale based on reliability and validity assessment in breast cancer patients</title><author>Cong, WeiLian ; Wu, YanNi ; Liu, LiPing ; Hu, MingYu ; Zhou, ChunLan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-aebeed568a2b6c3fcb459e20d06e9392717aca546409cd235654ef41f2c6721e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Alopecia</topic><topic>Alopecia - chemically induced</topic><topic>Alopecia - psychology</topic><topic>Analysis</topic><topic>Antineoplastic Agents - administration & dosage</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Asian People</topic><topic>Baldness</topic><topic>Body Image</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - drug therapy</topic><topic>Cancer</topic><topic>Cancer patients</topic><topic>Care and treatment</topic><topic>Chemotherapy</topic><topic>Cross-Sectional Studies</topic><topic>Factor Analysis, Statistical</topic><topic>Female</topic><topic>Humans</topic><topic>Language</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Nursing</topic><topic>Nursing Research</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Pain Medicine</topic><topic>Palliative care</topic><topic>Psychometrics - methods</topic><topic>Quality of Life</topic><topic>Rehabilitation Medicine</topic><topic>Reproducibility of Results</topic><topic>Surveys</topic><topic>Translating</topic><topic>Validity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cong, WeiLian</creatorcontrib><creatorcontrib>Wu, YanNi</creatorcontrib><creatorcontrib>Liu, LiPing</creatorcontrib><creatorcontrib>Hu, MingYu</creatorcontrib><creatorcontrib>Zhou, ChunLan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Sociology Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Social Science Database</collection><collection>Sociology Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Supportive care in cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cong, WeiLian</au><au>Wu, YanNi</au><au>Liu, LiPing</au><au>Hu, MingYu</au><au>Zhou, ChunLan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Chinese version of the chemotherapy-induced alopecia distress scale based on reliability and validity assessment in breast cancer patients</atitle><jtitle>Supportive care in cancer</jtitle><stitle>Support Care Cancer</stitle><addtitle>Support Care Cancer</addtitle><date>2020-09-01</date><risdate>2020</risdate><volume>28</volume><issue>9</issue><spage>4327</spage><epage>4336</epage><pages>4327-4336</pages><issn>0941-4355</issn><issn>1433-7339</issn><eissn>1433-7339</eissn><abstract>Purpose
Chemotherapy-induced alopecia is a common and emotionally traumatic side effect on breast cancer patients. In order to make up for the deficiency of measuring tools in China, our study aims at translating the chemotherapy-induced alopecia distress scale (CADS) into Chinese and evaluating the psychometric properties of the Chinese version of CADS (CADS-C) in breast cancer patients.
Methods
The validity and reliability of CADS-C were measured by a questionnaire survey among 301 breast cancer patients from Chinese mainland. Construct validity was assessed through factor analysis and contrasted group comparisons. The validity of the content was examined by an experts group. The internal consistency and test–retest reliability were evaluated by calculating Cronbach’s alpha and the intraclass correlation coefficient.
Results
The content validity index was 0.94; a structure with three factors was revealed by exploratory factor analysis which explained 65.40% of the variance and proved by confirmatory factor analysis. The contrasted group comparisons showed significant differences among different degrees of alopecia. The average variance extracted and composite reliability and correlations between CADS and body image, quality of life and self-esteem proved the convergent validity. The Cronbach’s alpha and the intraclass correlation coefficient of the total scale were 0.90 and 0.89 respectively, indicating satisfactory internal consistency and time stability.
Conclusion
The scale appears to be a reliable and valid tool to measure chemotherapy-induced alopecia distress among breast cancer patients in China.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>31912364</pmid><doi>10.1007/s00520-019-05284-0</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-2108-5627</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0941-4355 |
ispartof | Supportive care in cancer, 2020-09, Vol.28 (9), p.4327-4336 |
issn | 0941-4355 1433-7339 1433-7339 |
language | eng |
recordid | cdi_proquest_miscellaneous_2334700317 |
source | MEDLINE; SpringerLink Journals |
subjects | Adult Aged Alopecia Alopecia - chemically induced Alopecia - psychology Analysis Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Asian People Baldness Body Image Breast cancer Breast Neoplasms - drug therapy Cancer Cancer patients Care and treatment Chemotherapy Cross-Sectional Studies Factor Analysis, Statistical Female Humans Language Medicine Medicine & Public Health Middle Aged Nursing Nursing Research Oncology Original Article Pain Medicine Palliative care Psychometrics - methods Quality of Life Rehabilitation Medicine Reproducibility of Results Surveys Translating Validity |
title | A Chinese version of the chemotherapy-induced alopecia distress scale based on reliability and validity assessment in breast cancer patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T05%3A59%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Chinese%20version%20of%20the%20chemotherapy-induced%20alopecia%20distress%20scale%20based%20on%20reliability%20and%20validity%20assessment%20in%20breast%20cancer%20patients&rft.jtitle=Supportive%20care%20in%20cancer&rft.au=Cong,%20WeiLian&rft.date=2020-09-01&rft.volume=28&rft.issue=9&rft.spage=4327&rft.epage=4336&rft.pages=4327-4336&rft.issn=0941-4355&rft.eissn=1433-7339&rft_id=info:doi/10.1007/s00520-019-05284-0&rft_dat=%3Cgale_proqu%3EA630447340%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2426371629&rft_id=info:pmid/31912364&rft_galeid=A630447340&rfr_iscdi=true |